Close
Close
Treatment Database
NGR-human tumour necrosis factor
Trade Name not avaiable
Orphan Indication Malignant mesothelioma
EU Market Approval
EU Designation Date 03-06-2008
Sponsor MolMed S.p.A.
More about Malignant pleural mesothelioma
Free Newsletter
Related Videos